Cargando…
Efficacy and Safety of rAAV2-ND4 Treatment for Leber’s Hereditary Optic Neuropathy
Leber’s hereditary optic neuropathy (LHON) is a mitochondrially inherited disease leading to blindness. A mitochondrial DNA point mutation at the 11778 nucleotide site of the NADH dehydrogenase subunit 4 (ND4) gene is the most common cause. The aim of this study was to evaluate the efficacy and safe...
Autores principales: | Wan, Xing, Pei, Han, Zhao, Min-jian, Yang, Shuo, Hu, Wei-kun, He, Heng, Ma, Si-qi, Zhang, Ge, Dong, Xiao-yan, Chen, Chen, Wang, Dao-wen, Li, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759604/ https://www.ncbi.nlm.nih.gov/pubmed/26892229 http://dx.doi.org/10.1038/srep21587 |
Ejemplares similares
-
Prognostic factors for visual acuity in patients with Leber's hereditary optic neuropathy after rAAV2‐ND4 gene therapy
por: Zhang, Yong, et al.
Publicado: (2019) -
Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy
por: Yang, Shuo, et al.
Publicado: (2016) -
A Rare ND5 Mutation Causing Leber’s Hereditary Optic Neuropathy
por: Pandya, Bhadra U., et al.
Publicado: (2023) -
Developments in the Treatment of Leber Hereditary Optic Neuropathy
por: Chen, Benson S., et al.
Publicado: (2022) -
The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy
por: Zhang, Yong, et al.
Publicado: (2018)